Key statistics
On Wednesday, Novozymes A/S (0Q4U:LSE) closed at 430.95, -7.22% below its 52-week high of 464.50, set on Sep 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 426.45 |
|---|---|
| High | 430.95 |
| Low | 430.95 |
| Bid | 437.50 |
| Offer | 459.90 |
| Previous close | 428.95 |
| Average volume | 643.09k |
|---|---|
| Shares outstanding | 414.56m |
| Free float | 295.24m |
| P/E (TTM) | 42.41 |
| Market cap | 177.61bn DKK |
| EPS (TTM) | 10.10 DKK |
| Annual div (ADY) | 6.60 DKK |
|---|---|
| Annual div yield (ADY) | 1.54% |
| Div ex-date | Aug 25 2026 |
| Div pay-date | Aug 27 2026 |
Data delayed at least 20 minutes, as of Sep 16 2026 17:34 BST.
More ▼
- Initiation of Novonesis’ share buyback program
- Novonesis to build next generation enzyme production facility in India
- Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
- Trading by management and close relations of management
- H1 2026: Novonesis delivered strong 8% organic sales growth and increases full-year outlook
- Interim report H1 2026
- Announcement of share buyback program
- Increased outlook for 2026
- Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities
- Trading by management and close relations of management
More ▼
